Финам

      ROHTO PHARM CO

      ROHTO PHARM CO

      RPHCFBATSАкции

      22,35 $

      1,10 $

      5,18%

      9 авг. 2023 17:04

      Finam AI-скринер

      Фундаментальный анализ

      Показатели за последний квартал и их динамика за 5 кварталов и 10 лет

      Мультипликаторы

      Оценка стоимости
      Долговая нагрузка
      Рентабельность
      Другие мультипликаторы
      Выручка

      Финансовые показатели

      Прибыль
      Активы
      Долговая нагрузка

      О компании

      5,28 млрд $

      Капитализация

      236,18 млн

      Кол-во акций

      Потребительские товары повседневного спроса

      Сектор

      Предметы личного пользования

      Отрасль

      JP3982400008

      ISIN

      Размер лота

      Ген. директор

      Веб-сайт

      Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.